59169-66-3Relevant academic research and scientific papers
PRODUCTION OF INDUCED PLURIPOTENT STEM CELLS
-
Page/Page column 60-61, (2012/06/30)
The present disclosure relates to methods and compositions that improve the in vitro production of induced pluripotent stem cells through the use of compounds that promote degradation of p53. The disclosure also relates to compositions and methods for the treatment of cancer, pancreatitis and intracellular pathogens.
POTENT SMALL MOLECULE INHIBITORS OF AUTOPHAGY, AND METHODS OF USE THEREOF
-
Page/Page column 54-55, (2011/02/24)
Certain aspects of the invention relates to small molecule autophagy inhibitors, and their use for treatment and prevention of cancers and acute pancreatitis. As disclosed herein, a small molecule inhibitor of autophagy was been identified from an image-based screen in a known bioactive library. It was found that this autophagy inhibitor functions by promoting the degradation of type III PI3 kinase complex which is required for initiating autophagy. Medicinal chemistry studies led to small molecular autophagy inhibitors with improved potency and selectivity.
Discovery and SAR of 6-substituted-4-anilinoquinazolines as non-competitive antagonists of mGlu5
Felts, Andrew S.,Saleh, Sam A.,Le, Uyen,Rodriguez, Alice L.,Weaver, C. David,Conn, P. Jeffrey,Lindsley, Craig W.,Emmitte, Kyle A.
scheme or table, p. 6623 - 6626 (2010/06/12)
A high-throughput cell-based screen identified a series of 6-substituted-4-anilinoquinazolines as non-competitive antagonists of metabotropic glutamate receptor 5 (mGlu5). This Letter describes the SAR of this series and the profile of selected
